Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|November 7, 2018
[Prostate cancer screening: controversies and suggested solutions]Rouvier Al-Monajjed, Christian Arsov, Peter Albers
Urologic Oncology|October 2, 2010
Current second-line treatment options for patients with castration resistant prostate cancer (CRPC) resistant to docetaxelChristian Arsov, Christian Winter, Robert Rabenalt, et al.
World Journal of Urology|March 30, 2010
Extraperitoneal laparo-endoscopic single-site radical prostatectomy: first experienceRobert Rabenalt, Christian Arsov, Markus Giessing, et al.
The Journal of Urology|July 28, 2020
Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular CancerAndreas Hiester, Alessandro Nini, Christian Arsov, et al.
Urologic Oncology|August 2, 2011
Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosisAnna Vinarskaja, Wolfgang A Schulz, Marc Ingenwerth, et al.
European Radiology|September 3, 2013
Increased signal intensity of prostate lesions on high b-value diffusion-weighted images as a predictive sign of malignancyMichael Quentin, Lars Schimmöller, Christian Arsov, et al.
International Journal of Cancer|May 11, 2012
The SNP rs6441224 influences transcriptional activity and prognostically relevant hypermethylation of RARRES1 in prostate cancerMichael Kloth, Wolfgang Goering, Teodora Ribarska, et al.
AJR. American Journal of Roentgenology|December 25, 2015
MRI-Guided In-Bore Biopsy: Differences Between Prostate Cancer Detection and Localization in Primary and Secondary Biopsy SettingsLars Schimmöller, Dirk Blondin, Christian Arsov, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|July 24, 2013
3-T in-bore MR-guided prostate biopsy based on a scoring system for target lesions characterizationMichael Quentin, Lars Schimmöller, Christian Arsov, et al.
Pageof 6